{
  "id": 8545897,
  "title": "Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds",
  "url": "https://urgent.news/2026/09/19/cardinal-health-targets-13-15-eps-growth-as-specialty-momentum-builds",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-19T22:01:57.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/healthcare/articles/cardinal-health-targets-13-15-220157006.html"
  },
  "original_language": "en",
  "account": "Cardinal Health expects its adjusted earnings per share (EPS) to grow between 13% and 15% in fiscal 2027, driven by the expansion of operating income across its business segments. The company continues to aim for a longer-term EPS growth target of 12% to 14%, and plans to repurchase $1 billion in shares. Specialty services, which grew by 25% in fiscal 2026, are expected to continue contributing to the company's growth. Cardinal Health anticipates double-digit growth in this segment, alongside the expansion of its BioPharma Solutions business, which aims to reach $1 billion in revenue by fiscal 2028. The medical-products division remains focused on recovery after overcoming significant challenges, such as a $450 million tariff impact. CEO Jason Hollar highlighted a constructive period for the company in fiscal 2027, with all five operating segments positioned for growth.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}